Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

San Diego Convention Center

Jun 15, 2014 8:30 AM - Jun 19, 2014 12:45 PM

111 W Harbor Drive, , San Diego, CA 92101 , USA

DIA 2014 50th Annual Meeting "Celebrate the Past - Invent the Future"

Clinical Study Risk Management: What Does It Really Mean and How Do You Do It? (Part 2 of 2)

Session Chair(s)

Liz  Wool, BSN

Liz Wool, BSN

President

Wool Consulting Group Inc., United States

The lessons learned from Part 1 of this two-part workshop will provide the foundation for participants to apply the learned principles. Participants will have the opportunity to develop a study risk plan, identify and prioritize the risks, and determine a control plan (including tolerance levels). Participants will analyze factors critical to quality and successful study execution for the development of a risk management plan.

This workshop has been developed by the DIA Data Management, Good Clinical Practice/Quality Assurance, Quality Risk Management, and Statistics Communities.

Preregistration is strongly recommended, and attendees are expected to attend both Part 1 and Part 2.

Part 1 will take place on Wednesday at 1:30 pm (Session #367).

To secure a seat for this specific workshop, please email annualmeetingprogram@diahome.org, Subject line: Clinical Study Risk Management Workshop.

**Due to workshop format, seating will be limited and will be available on a first come, first served basis.

The San Diego Convention Center has stringent regulations on maximum room capacities, and they are strictly enforced. Once all seats are occupied, DIA will be required to close the workshop, and no more participants will be admitted. Interested attendees are encouraged to arrive at workshops early in order to ensure seating. Please note, as a workshop with interactivity, this offering will not be recorded.

Learning Objective : Identify the foundational principles discussed in the Part 1 workshop to develop a study risk plan; Perform critical analysis of study risk plan.

Speaker(s)

Johann  Proeve, PhD

Facilitator

Johann Proeve, PhD

Cyntegrity, Germany

International Medical Officer

Kristin M. Neff, MS

Facilitator

Kristin M. Neff, MS

InVivo Therapeutics, United States

Vice President, Clinical Operations and Project Management

Dale  Usner, PhD

Facilitator

Dale Usner, PhD

Statistics & Data Corporation (SDC), United States

CSO and Sr. VP, Strategic Scientific Consulting

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.